Money Makers Mentor

Clinical Ink Acquired By GI Partners in Impactful Deal

Today, GI Partners announced its acquisition of Clinical Ink, a global clinical trial technology company. NovaQuest, an existing investor in Clinical Ink, will continue as a minority investor in the company. Clinical Ink’s management team also invested significantly in the transaction.

In a time of unprecedented uncertainty, the acquisition and continued investment by Clinical Ink’s management team and NovaQuest is a testament to strong financial performance amongst the companies. 

“GI Partners’ acquisition is a powerful validation of our eSource vision for clinical trials and will add to our growing momentum in the marketplace,” Clinical Ink CEO, Ed Seguine, said. “We are the undeniable leader in delivering eSource solutions across all phases and therapeutic areas. This transa…

Leave A Reply

Your email address will not be published.